Request Sample Inquiry
Opioids Drugs Market

Opioids Drugs Market

Opioids Drugs Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

278

Base Year:

2023

Date

Nov - 2024

Format:

PDF XLS PPT

Report Code:

VMR-VMR-2021-0205

Segments Covered
  • By Product By Product Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone, Others
  • By Application By Application Pain Management, Cough Treatment, Diarrhea
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 22.9 Billion
Revenue 2032Revenue 2032: USD 27.38 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 1.98%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia-Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
Opioids Drugs Market Share

Key Insights

The Global Opioids Drugs Market is valued at USD 22.9 Billion in 2024 and is projected to reach a value of USD 27.38 Billion by 2034 at a CAGR (Compound Annual Growth Rate) of 1.98% between 2024 and 2034

Overview and Description

Opioids are substances that act on opioid receptors to produce morphine-like effects. Medically they are primarily used for pain relief, including anesthesia. Other medical uses include suppression of diarrhea, replacement therapy for opioid use disorder, reversing opioid overdose, suppressing cough.

This report provides an analysis of the Opioids Drugs market for the historic period of 2016–2019 and forecasts for 204–2034 while 2022 is considered as a base year for estimations. The report includes exhaustive analysis of segments, regions and countries comprising of market size and estimations in terms of revenue for the years 2019–2034. There regional section of the report is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, the report also covers a thorough insights on various tools such as SWOT analysis, PEST analysis, value chain analysis, Porter’s five forces analysis, pricing analysis, and technology roadmap among others. These assessments aid the industry stakeholders to analyze the Opioids Drugs market on the basis of different parameters, such as forward/backward integration, economies of scale, the share of various distribution channels, various factors affecting consumer behavior such as brand loyalty, price, and product availability among others, capital investments, regulatory landscape, production rights and patents, promotional strategies, and other customer preferences. This data is likely to help the industry stakeholders and stimulate the decision-making process.

Opioids Drugs Market Size, 2023 To 2032 (USD Billion)

AI (GPT) is here !!! Ask questions about Opioids Drugs Market
Loading....

COVID-19 Impact Analysis

The COVID-19 outbreak has affected various industries worldwide. The Opioids Drugs market is no exception. Governments across the world took severe actions like border seals, lockdown, and implementing strict social distancing measures, in order to stop swift spread of COVID-19. These actions led to severe impact on the global economy. Industrialist across the globe were forced to halt their production, leading to supply chain disruptions and impairing of various industries. However, it is expected that reopening of trade activities, the market will witness steady growth in demand in the coming years. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends for all the regions and countries.

The report provides a completely separate chapter for COVID-19 Impact Analysis. This chapter includes:

  • Impact Assessment of COVID-19 Pandemic
  • Pre & Post COVID-19 Market Size
  • Qualitative analysis on the short term & long-term impact of COVID-19 on the market
  • The analysis provides foremost strategies adopted by competitors to minimize the impact of the pandemic on their business activities and scope for future developments.

Industry Analysis

The report covers exhaustive analysis on the global Opioids Drugs industry, which includes market trends, drivers, restraints, opportunities, segmental analysis, regional trends, and competitive landscape among others. It includes an extensive competitive landscape covering key players in the industry and their comparative study on the basis of different parameters such as company overview, product portfolio, market revenue, business, and marketing strategies. Moreover, the report covers a thorough analysis drivers, restraints, and opportunities considering regional growth factors, technological advancements, and availability of substitute, regulatory norms, and such other growth impacting factors.

  • Opioids minimize the depth of pain and are usually secure when taken as recommended by the healthcare specialists for smaller duration.
  • Opioids are generally used to cure pain related with cancer, rheumatic diseases, or sleep disorders, anxiety, and severe pain with respect to diarrhea & coughing. Since opioids efficiently alleviates chronic pain, and addiction in the individuals.
  • Opioids addictive character has led to drug abuse. Opioid consumption may cause various side effects including drowsiness, constipation, confusion, slowed breathing, nausea, and euphoria.

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

  • Real-Time Data Updates:
  • Competitor Benchmarking
  • Market Trends Heatmap
  • Custom Research Queries
  • Market Sentiment Analysis
  • Demographic and Geographic Insights

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Segmentation

The report delivers an acute breakdown of the market based on various segments such as Product, Application, and region. The report will cover market estimations and forecast for each segment by region for the years 2019–2034. Several growth factors and opportunities impacting various segments have been incorporated in the report.

On the basis of Product, the market is divided into Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone, Others. oxycodone held the largest share in 2022 and is projected to witness substantial growth during the forecast period.

Based on Application, the market is divided into Pain Management, Cough Treatment, Diarrhea. pain management attributed to the highest market share and is expected to grow at a significant CAGR from 204 to 2034.

Regional Analysis: Preview

Based on the geography, the global Opioids Drugs market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. The regional analysis covers market estimations and forecast for each segment for each region for the years 2019–2034. The regional analysis section also provides qualitative analysis comprising of regional trends such as drivers, restraints, opportunities and regulatory norms. Moreover, the regional sections if further bifurcated into key country level markets for better understanding of the market.

Competitive Landscape

The global Opioids Drugs market report provides an exhaustive competitive landscape to give a comprehensive synopsis of the global market. Major players in the Opioids Drugs market are Allergan, Orexo Pharmaceuticals, Purdue Pharma, Pfizer, AbbVie, Teva pharmaceuticals, Johnson & Johnson, Endo Pharmaceuticals, Sanofi-aventis US LLC, Hospira.. This section of the report comprising of a thorough profiling of companies based on various parameters such as company/business overview, portfolio analysis, business strategies, financial performance, geographical presence, and recent developments among others. Moreover, the report also includes extensive information on key strategies such as new product development/launch, merger & acquisitions, partnerships, collaborations & joint ventures, research & development, and regional expansion.

The global Opioids Drugs market can be categorized as Type, Application, End-Use Industry, and Region.

Parameter Details
Segments Covered

By Product

  • Codeine
  • Fentanyl
  • Methadone
  • Oxycodone
  • Morphine
  • Hydrocodone
  • Others

By Application

  • Pain Management
  • Cough Treatment
  • Diarrhea

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Allergan
  • Orexo Pharmaceuticals
  • Purdue Pharma
  • Pfizer
  • AbbVie
  • Teva pharmaceuticals
  • Johnson & Johnson
  • Endo Pharmaceuticals
  • Sanofi-aventis US LLC
  • Hospira.
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis
Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Explore purchase options

FAQ
Frequently Asked Question
  • The global Opioids Drugs valued at USD 22.9 Billion in 2023 and is expected to reach USD 27.38 Billion in 2032 growing at a CAGR of 1.98%.

  • The prominent players in the market are Allergan, Orexo Pharmaceuticals, Purdue Pharma, Pfizer, AbbVie, Teva pharmaceuticals, Johnson & Johnson, Endo Pharmaceuticals, Sanofi-aventis US LLC, Hospira..

  • The market is project to grow at a CAGR of 1.98% between 2024 and 2032.

  • The driving factors of the Opioids Drugs include

  • North America was the leading regional segment of the Opioids Drugs in 2023.